Comment on: Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.

Underwood, Patrick W; Cloyd, Jordan M

Underwood, Patrick W; Cloyd, Jordan M.

Affiliation

Underwood PW; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Cloyd JM; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Br J Surg ; 111(4)2024 Apr 03.

Article in En | MEDLINE | ID: mdl-38568860

Subject(s)

Adenocarcinoma; Pancreatic Neoplasms; Humans; Neoadjuvant Therapy/adverse effects; Randomized Controlled Trials as Topic; Pancreatic Neoplasms/surgery; Chemoradiotherapy; Carbohydrates/therapeutic use; Antineoplastic Combined Chemotherapy Protocols; Pancreatectomy/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Limits: Humans Language: En Journal: Br J Surg Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google